BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 11064925)

  • 1. Prevalence of Down syndrome in Glasgow, 1980-96--the growing impact of prenatal diagnosis on younger mothers.
    Iliyasu Z; Gilmour WH; Stone DH
    Health Bull (Edinb); 2002 Jan; 60(1):20-6. PubMed ID: 12664764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prenatal diagnosis of Down syndrome and other autosomal trisomies in Scotland 1990 to 1994, with associated cytogenetic and epidemiological findings.
    Carothers AD; Boyd E; Lowther G; Ellis PM; Couzin DA; Faed MJ; Robb A
    Genet Epidemiol; 1999; 16(2):179-90. PubMed ID: 10030400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current French practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97.
    De Vigan C; Vodovar V; Vérité V; Dehé S; Goujard J
    Prenat Diagn; 1999 Dec; 19(12):1113-8. PubMed ID: 10590427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends in the prevalence of Down syndrome in north-eastern France.
    Stoll C; Alembik Y; Dott B; Roth MP
    Ann Genet; 1994; 37(4):179-83. PubMed ID: 7710252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome.
    Guedj F; Bianchi DW
    Prenat Diagn; 2013 Jun; 33(6):614-8. PubMed ID: 23595836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Approaches to an Integrated Route for Trisomy 21 Evaluation.
    Buczyńska A; Sidorkiewicz I; Trochimiuk A; Ławicki S; Krętowski AJ; Zbucka-Krętowska M
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trisomy 21 and breast cancer: A genetic abnormality which protects against breast cancer?].
    Martel-Billard C; Cordier C; Tomasetto C; Jégu J; Mathelin C
    Gynecol Obstet Fertil; 2016 Apr; 44(4):211-7. PubMed ID: 27032759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trisomy 21 and its prenatal detection in the Canton of Vaud (1980-1996)].
    Pescia G; Addor MC
    Schweiz Med Wochenschr; 2000 Sep; 130(38):1332-8. PubMed ID: 11064925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paper 2: EUROCAT public health indicators for congenital anomalies in Europe.
    Khoshnood B; Greenlees R; Loane M; Dolk H; ;
    Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1(Suppl 1):S16-22. PubMed ID: 21381186
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.